Evologic International Limited (SGX:1H2)
Singapore · Delayed Price · Currency is SGD 0.1200
0.00 (0.00%)
At close: May 12, 2026
Evologic International Balance Sheet
Financials in millions SGD. Fiscal year is January - December.
Millions SGD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 6.16 | 7.19 | 1.94 | 4.56 | 7.15 | 2.63 |
Short-Term Investments | 0.06 | 0 | 0.01 | 0.01 | 0.01 | 0.01 |
Cash & Short-Term Investments | 6.22 | 7.19 | 1.95 | 4.57 | 7.16 | 2.64 |
Cash Growth | -25.28% | 268.00% | -57.25% | -36.21% | 171.25% | 48.07% |
Accounts Receivable | 0.11 | 0.01 | 0.12 | - | - | 0.11 |
Other Receivables | 0.01 | 0.04 | 0.1 | 0.11 | 0.12 | 0.08 |
Receivables | 0.12 | 0.05 | 0.22 | 0.79 | 0.12 | 0.18 |
Prepaid Expenses | 0.02 | 0.01 | 0.01 | 0.01 | 0.02 | 0.01 |
Other Current Assets | 7.04 | - | 8.07 | - | - | - |
Total Current Assets | 13.4 | 7.25 | 10.25 | 5.37 | 7.3 | 2.84 |
Property, Plant & Equipment | - | - | 0.03 | 0.08 | - | - |
Long-Term Investments | - | - | - | 4.89 | 4.81 | 4.96 |
Other Long-Term Assets | - | 7.34 | 7.94 | 8.62 | 9.27 | 9.93 |
Total Assets | 13.4 | 14.59 | 18.22 | 20.85 | 23.93 | 20.5 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accrued Expenses | 0.06 | 0.05 | 0.2 | 0.07 | 0.13 | 0.16 |
Current Portion of Long-Term Debt | 0.86 | 1.08 | 2.16 | 2.11 | 2.04 | 1.86 |
Current Portion of Leases | - | - | 0.03 | 0.05 | - | - |
Current Income Taxes Payable | 0.08 | 0.08 | 0.08 | 0.12 | 0.15 | 0.08 |
Current Unearned Revenue | 0.1 | - | 0.11 | - | 0.1 | 0.1 |
Other Current Liabilities | 0.33 | 0.32 | 0.32 | 0.48 | 0.62 | 1.5 |
Total Current Liabilities | 1.44 | 1.53 | 2.88 | 2.83 | 3.04 | 3.7 |
Long-Term Debt | 3.25 | 3.68 | 4.76 | 6.92 | 9.03 | 10.81 |
Long-Term Leases | - | - | - | 0.03 | - | - |
Other Long-Term Liabilities | 0.93 | 0.94 | 0.97 | 0.85 | 0.76 | - |
Total Liabilities | 5.61 | 6.15 | 8.61 | 10.63 | 12.83 | 14.51 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 63.22 | 63.22 | 63.22 | 63.22 | 63.22 | 7.95 |
Retained Earnings | -55.41 | -54.76 | -53.29 | -52.76 | -51.99 | 8.63 |
Treasury Stock | -0.02 | -0.02 | -0.02 | -0.02 | -0.02 | - |
Comprehensive Income & Other | - | - | -0.29 | -0.22 | -0.11 | -10.59 |
Shareholders' Equity | 7.79 | 8.44 | 9.62 | 10.22 | 11.1 | 5.99 |
Total Liabilities & Equity | 13.4 | 14.59 | 18.22 | 20.85 | 23.93 | 20.5 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 4.11 | 4.76 | 6.94 | 9.1 | 11.07 | 12.67 |
Net Cash (Debt) | 2.11 | 2.43 | -4.99 | -4.54 | -3.91 | -10.03 |
Net Cash Growth | -14.89% | - | - | - | - | - |
Net Cash Per Share | 0.02 | 0.02 | -0.04 | -0.04 | -0.06 | -0.15 |
Filing Date Shares Outstanding | 115.85 | 115.85 | 115.85 | 115.85 | 115.85 | 68.85 |
Total Common Shares Outstanding | 115.85 | 115.85 | 115.85 | 115.85 | 115.85 | 68.85 |
Working Capital | 11.97 | 5.72 | 7.37 | 2.54 | 4.25 | -0.86 |
Book Value Per Share | 0.07 | 0.07 | 0.08 | 0.09 | 0.10 | 0.09 |
Tangible Book Value | 7.79 | 8.44 | 9.62 | 10.22 | 11.1 | 5.99 |
Tangible Book Value Per Share | 0.07 | 0.07 | 0.08 | 0.09 | 0.10 | 0.09 |
Machinery | 0 | 0 | 0.01 | 0.01 | 0.01 | - |